Total Liabilities Summary of QuidelOrtho Corporation

QuidelOrtho Corporation's latest annual total liabilities in 2023 was 3.55 Billion USD , down -9.28% from previous year.
QuidelOrtho Corporation's latest quarterly total liabilities in 2024 Q2 was 3.51 Billion USD , up 3.54% from previous quarter.
QuidelOrtho Corporation reported annual total liabilities of 3.92 Billion USD in 2022, up 682.66% from previous year.
QuidelOrtho Corporation reported annual total liabilities of 501.01 Million USD in 2021, down -6.95% from previous year.
QuidelOrtho Corporation reported quarterly total liabilities of 3.51 Billion USD for 2024 Q2, up 3.54% from previous quarter.
QuidelOrtho Corporation reported quarterly total liabilities of 3.79 Billion USD for 2023 Q1, down -3.33% from previous quarter.

Annual Total Liabilities Chart of QuidelOrtho Corporation (2023 - 1989)

Historical Annual Total Liabilities of QuidelOrtho Corporation (2023 - 1989)

Year	Total Liabilities	Total Liabilities Growth
2023	3.55 Billion USD	-9.28%
2022	3.92 Billion USD	682.66%
2021	501.01 Million USD	-6.95%
2020	538.46 Million USD	53.39%
2019	351.04 Million USD	-7.81%
2018	380.78 Million USD	-46.23%
2017	708.14 Million USD	277.44%
2016	187.62 Million USD	-0.11%
2015	187.82 Million USD	-9.06%
2014	206.53 Million USD	331.69%
2013	47.84 Million USD	14.27%
2012	41.86 Million USD	-55.22%
2011	93.5 Million USD	-8.39%
2010	102.07 Million USD	147.47%
2009	41.24 Million USD	74.98%
2008	23.57 Million USD	-9.81%
2007	26.13 Million USD	9.94%
2006	23.77 Million USD	-10.65%
2005	26.6 Million USD	18.21%
2004	22.5 Million USD	-18.59%
2003	27.64 Million USD	39.36%
2002	19.83 Million USD	-9.77%
2001	21.98 Million USD	-7.34%
2000	23.72 Million USD	0.0%
1998	7.9 Million USD	-27.52%
1997	10.9 Million USD	53.52%
1996	7.1 Million USD	-6.58%
1995	7.6 Million USD	-28.3%
1994	10.6 Million USD	0.0%
1993	10.6 Million USD	2.91%
1992	10.3 Million USD	7.29%
1991	9.6 Million USD	-38.06%
1990	15.5 Million USD	142.19%
1989	6.4 Million USD	3.23%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	3.39 Billion USD	-4.54%
2024 Q2	3.51 Billion USD	3.54%
2023 Q1	3.79 Billion USD	-3.33%
2023 FY	3.55 Billion USD	-9.28%
2023 Q4	3.55 Billion USD	-0.43%
2023 Q3	3.57 Billion USD	0.69%
2023 Q2	3.54 Billion USD	-6.41%
2022 Q4	3.92 Billion USD	1.58%
2022 FY	3.92 Billion USD	682.66%
2022 Q1	678.2 Million USD	35.37%
2022 Q3	3.86 Billion USD	-1.09%
2022 Q2	3.9 Billion USD	475.46%
2021 Q3	472.31 Million USD	19.1%
2021 FY	501.01 Million USD	-6.95%
2021 Q2	396.57 Million USD	-34.74%
2021 Q4	501.01 Million USD	6.08%
2021 Q1	607.65 Million USD	12.85%
2020 Q4	538.46 Million USD	34.58%
2020 Q2	361.22 Million USD	-0.1%
2020 FY	538.46 Million USD	53.39%
2020 Q1	361.56 Million USD	3.0%
2020 Q3	400.11 Million USD	10.77%
2019 Q3	333.35 Million USD	-0.85%
2019 Q4	351.04 Million USD	5.31%
2019 Q1	445.15 Million USD	16.9%
2019 Q2	336.21 Million USD	-24.47%
2019 FY	351.04 Million USD	-7.81%
2018 FY	380.78 Million USD	-46.23%
2018 Q2	394.59 Million USD	-26.24%
2018 Q3	405.43 Million USD	2.75%
2018 Q4	380.78 Million USD	-6.08%
2018 Q1	534.99 Million USD	-24.45%
2017 Q4	708.14 Million USD	263.27%
2017 Q2	185.94 Million USD	0.85%
2017 Q1	184.37 Million USD	-1.73%
2017 Q3	194.93 Million USD	4.83%
2017 FY	708.14 Million USD	277.44%
2016 FY	187.62 Million USD	-0.11%
2016 Q3	179.75 Million USD	1.75%
2016 Q4	187.62 Million USD	4.38%
2016 Q1	180.35 Million USD	-3.98%
2016 Q2	176.66 Million USD	-2.05%
2015 Q1	203.74 Million USD	-1.35%
2015 Q2	199.09 Million USD	-2.28%
2015 Q3	199.62 Million USD	0.27%
2015 Q4	187.82 Million USD	-5.91%
2015 FY	187.82 Million USD	-9.06%
2014 Q1	46.41 Million USD	-2.99%
2014 Q2	38.66 Million USD	-16.69%
2014 FY	206.53 Million USD	331.69%
2014 Q4	206.53 Million USD	310.1%
2014 Q3	50.36 Million USD	30.24%
2013 Q1	38.65 Million USD	-7.67%
2013 FY	47.84 Million USD	14.27%
2013 Q4	47.84 Million USD	-7.17%
2013 Q3	51.53 Million USD	12.99%
2013 Q2	45.61 Million USD	17.99%
2012 FY	41.86 Million USD	-55.22%
2012 Q4	41.86 Million USD	-16.44%
2012 Q3	50.1 Million USD	2.78%
2012 Q2	48.75 Million USD	-7.87%
2012 Q1	52.91 Million USD	-43.41%
2011 FY	93.5 Million USD	-8.39%
2011 Q2	72.73 Million USD	-9.02%
2011 Q1	79.94 Million USD	-21.68%
2011 Q4	93.5 Million USD	2.81%
2011 Q3	90.95 Million USD	25.05%
2010 Q1	112.18 Million USD	181.19%
2010 FY	102.07 Million USD	147.47%
2010 Q4	102.07 Million USD	-0.19%
2010 Q3	102.26 Million USD	-2.91%
2010 Q2	105.33 Million USD	-6.1%
2009 Q3	31.68 Million USD	72.88%
2009 Q1	18.27 Million USD	-22.46%
2009 FY	41.24 Million USD	74.98%
2009 Q2	18.33 Million USD	0.28%
2009 Q4	39.89 Million USD	25.9%
2008 Q4	23.57 Million USD	-1.98%
2008 Q1	23.24 Million USD	-11.05%
2008 FY	23.57 Million USD	-9.81%
2008 Q3	24.04 Million USD	17.38%
2008 Q2	20.48 Million USD	-11.86%
2007 FY	26.13 Million USD	9.94%
2007 Q1	21.12 Million USD	-11.13%
2007 Q2	20.84 Million USD	-1.32%
2007 Q3	22.16 Million USD	6.3%
2007 Q4	26.13 Million USD	17.93%
2006 Q4	23.77 Million USD	1.22%
2006 FY	23.77 Million USD	-10.65%
2006 Q3	23.48 Million USD	13.32%
2006 Q2	20.72 Million USD	-6.93%
2006 Q1	22.26 Million USD	-16.3%
2005 Q3	22.68 Million USD	29.28%
2005 Q1	37.58 Million USD	67.0%
2005 Q2	17.54 Million USD	-53.31%
2005 Q4	26.6 Million USD	17.29%
2005 FY	26.6 Million USD	18.21%
2004 Q1	22.61 Million USD	-18.18%
2004 FY	22.5 Million USD	-18.59%
2004 Q2	21.16 Million USD	-6.42%
2004 Q4	22.5 Million USD	2.64%
2004 Q3	21.92 Million USD	3.6%
2003 Q2	17.89 Million USD	-11.93%
2003 Q3	21.76 Million USD	21.61%
2003 FY	27.64 Million USD	39.36%
2003 Q1	20.32 Million USD	2.43%
2003 Q4	27.64 Million USD	27.03%
2002 Q2	16.71 Million USD	-2.6%
2002 Q1	17.15 Million USD	-21.95%
2002 Q4	19.83 Million USD	19.13%
2002 FY	19.83 Million USD	-9.77%
2002 Q3	16.65 Million USD	-0.36%
2001 FY	21.98 Million USD	-7.34%
2001 Q2	19.41 Million USD	-11.41%
2001 Q4	21.98 Million USD	2.19%
2001 Q3	21.51 Million USD	10.82%
2001 Q1	21.91 Million USD	-7.65%
2000 Q4	23.72 Million USD	20.62%
2000 FY	23.72 Million USD	0.0%
2000 Q3	19.66 Million USD	-11.54%
2000 Q2	22.23 Million USD	-4.73%
2000 Q1	23.33 Million USD	0.0%
1999 Q3	16.4 Million USD	164.52%
1999 Q1	7.9 Million USD	-11.24%
1999 Q2	6.2 Million USD	-21.52%
1998 Q4	8.9 Million USD	-11.0%
1998 Q2	9.7 Million USD	-11.01%
1998 Q1	10.9 Million USD	25.29%
1998 FY	7.9 Million USD	-27.52%
1998 Q3	10 Million USD	3.09%
1997 Q4	8.7 Million USD	22.54%
1997 Q3	7.1 Million USD	-1.39%
1997 Q2	7.2 Million USD	1.41%
1997 Q1	7.1 Million USD	1.43%
1997 FY	10.9 Million USD	53.52%
1996 Q1	7.6 Million USD	-7.32%
1996 Q4	7 Million USD	2.94%
1996 Q3	6.8 Million USD	-6.85%
1996 Q2	7.3 Million USD	-3.95%
1996 FY	7.1 Million USD	-6.58%
1995 Q2	8.7 Million USD	-17.92%
1995 Q1	10.6 Million USD	4.95%
1995 FY	7.6 Million USD	-28.3%
1995 Q4	8.2 Million USD	2.5%
1995 Q3	8 Million USD	-8.05%
1994 Q2	9.6 Million USD	-9.43%
1994 Q1	10.6 Million USD	324.0%
1994 FY	10.6 Million USD	0.0%
1994 Q3	10.6 Million USD	10.42%
1994 Q4	10.1 Million USD	-4.72%
1993 Q3	2.1 Million USD	-76.67%
1993 Q4	2.5 Million USD	19.05%
1993 FY	10.6 Million USD	2.91%
1993 Q2	9 Million USD	-12.62%
1993 Q1	10.3 Million USD	10.75%
1992 Q1	9.6 Million USD	1.05%
1992 Q4	9.3 Million USD	-2.11%
1992 FY	10.3 Million USD	7.29%
1992 Q2	8.9 Million USD	-7.29%
1992 Q3	9.5 Million USD	6.74%
1991 Q3	10 Million USD	-13.04%
1991 Q1	15.5 Million USD	0.0%
1991 FY	9.6 Million USD	-38.06%
1991 Q4	9.5 Million USD	-5.0%
1991 Q2	11.5 Million USD	-25.81%
1990 Q1	6.4 Million USD	0.0%
1990 FY	15.5 Million USD	142.19%
1989 Q1	6.2 Million USD	0.0%
1989 FY	6.4 Million USD	3.23%

Peer Total Liabilities Comparison of QuidelOrtho Corporation

Name	Total Liabilities	Total Liabilities Difference
Accelerate Diagnostics, Inc.	51.25 Million USD	-6840.336%

Global Stocks Search

QuidelOrtho Corporation (0A55.L)

Total Liabilities Summary of QuidelOrtho Corporation

Annual Total Liabilities Chart of QuidelOrtho Corporation (2023 - 1989)

Historical Annual Total Liabilities of QuidelOrtho Corporation (2023 - 1989)

Peer Total Liabilities Comparison of QuidelOrtho Corporation